{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:06:24Z","timestamp":1784009184438,"version":"3.55.0"},"posted":{"date-parts":[[2026,4,13]]},"group-title":"In Review","reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,22]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Purpose:<\/bold>\n                  To investigate whether specific imaging biomarkers predict progression to neovascular AMD (nAMD) or geographic atrophy (GA) in eyes with high-risk intermediate age-related macular degeneration (iAMD) and avascular pigment epithelial detachment (PED).\n                  <bold>Methods:<\/bold>\n                  Prospective longitudinal cohort study of eyes with iAMD and avascular PED from the University of Colorado AMD registry (August 2014 - August 2023) with \u22651 month of follow-up through February 2024. Multimodal imaging, including color fundus photos (CFP), fundus autofluorescence (FAF), and optical coherence tomography (OCT), was graded by two reviewers for presence of specific imaging biomarkers. Time-to-progression survival analysis was conducted with hazard ratios calculated.\n                  <bold>Results:<\/bold>\n                  Over a median follow-up period of 35 months, 224 eyes (142 patients) were included. 31 (13.8%) eyes progressed to nAMD, and 63 (28.1%) to GA. Progression to nAMD was significantly predicted by pigmentary changes on CFP (HR=4.43 (95%CI: 1.77, 11.1), p=0.001) and intraretinal hyperreflective foci (iHRF) on OCT (HR=4.90 (95%CI: 2.02, 11.9), p=0.0005). Progression to GA was significantly predicted by pigmentary changes on CFP (HR=3.60 (95%CI: 1.94, 6.67), p&lt;0.0001), iHRF (HR=4.13 (95%CI: 2.14, 7.94), p&lt;0.0001), acquired vitelliform lesions (AVL; (HR=2.97 (95%CI: 1.55, 5.68), p=0.001)) and incomplete retinal pigment epithelium and outer retina atrophy (iRORA; (HR=4.18 (95%CI: 1.52, 11.4), p=0.006)). No other biomarkers demonstrated significance.\n                  <bold>Conclusion:<\/bold>\n                  In eyes with avascular PED, pigmentary changes and iHRF were significantly associated with progression to nAMD and GA, while AVL and iRORA were specifically to GA. We highlight in this study important imaging biomarkers that help identify high-risk eyes that may warrant closer monitoring to ensure timely therapeutic intervention.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9193520\/v1","type":"posted-content","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:51:02Z","timestamp":1776095462000},"source":"Crossref","is-referenced-by-count":0,"title":["Imaging Biomarkers To Predict Progression of Intermediate AMD with Avascular Pigment Epithelial Detachment in the University of Colorado AMD Registry"],"prefix":"10.21203","author":[{"given":"Soufiane","family":"Azargui","sequence":"first","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Lisker-Cervantes","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Patnaik","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Gnanaraj","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihaal","family":"Mehta","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Gange","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Lynch","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T.","family":"Mathias","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan","family":"Manoharan","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Mandava","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talisa E. Carlo","family":"Forest","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0039-6257(03)00030-4","article-title":"Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies","volume":"48","author":"Ambati J","year":"2003","unstructured":"Ambati J et al (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48(3):257\u2013293","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong WL","year":"2014","unstructured":"Wong WL et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health 2(2):e106\u2013e116","journal-title":"Lancet Global Health"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.survophthal.2007.02.008","article-title":"Retinal pigment epithelial detachment","volume":"52","author":"Zayit-Soudry S","year":"2007","unstructured":"Zayit-Soudry S, Moroz I, Loewenstein A (2007) Retinal pigment epithelial detachment. Surv Ophthalmol 52(3):227\u2013243","journal-title":"Surv Ophthalmol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ajo.2016.09.004","article-title":"A perspective on the nature and frequency of pigment epithelial detachments","volume":"172","author":"Tan AC","year":"2016","unstructured":"Tan AC et al (2016) A perspective on the nature and frequency of pigment epithelial detachments. Am J Ophthalmol 172:13\u201327","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/IAE.0b013e3182993f66","article-title":"Multimodal imaging of pigment epithelial detachment: a guide to evaluation","volume":"33","author":"Mrejen S","year":"2013","unstructured":"Mrejen S (2013) Multimodal imaging of pigment epithelial detachment: a guide to evaluation. Retina 33(9):1735\u20131762","journal-title":"Retina"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40123-020-00291-5","article-title":"Retinal pigment epithelial detachment in age-related macular degeneration","volume":"9","author":"Karampelas M","year":"2020","unstructured":"Karampelas M et al (2020) Retinal pigment epithelial detachment in age-related macular degeneration. Ophthalmol Therapy 9(4):739\u2013756","journal-title":"Ophthalmol Therapy"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.69.6.397","article-title":"Retinal pigment epithelial detachments in the elderly: classification and outcome","volume":"69","author":"Casswell A","year":"1985","unstructured":"Casswell A, Kohen D, Bird A (1985) Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 69(6):397\u2013403","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(97)30368-6","article-title":"The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study","volume":"104","author":"Klein R","year":"1997","unstructured":"Klein R et al (1997) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104(1):7\u201321","journal-title":"Ophthalmology"},{"key":"ref9","author":"Jeannette JY","year":"2019","unstructured":"Jeannette JY et al (2019) Natural history of drusenoid pigment epithelial detachment associated with age-related macular degeneration: age-related eye disease study 2 report no. 17. Ophthalmology, 126(2): pp. 261\u2013273"},{"issue":"1","key":"ref10","first-page":"11","article-title":"Classification of retinal pigment epithelial detachments associated with drusen. Graefe's archive for clinical and experimental ophthalmology","volume":"230","author":"Hartnett ME","year":"1992","unstructured":"Hartnett ME et al (1992) Classification of retinal pigment epithelial detachments associated with drusen. Graefe's archive for clinical and experimental ophthalmology. 230(1):11\u201319"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/IAE.0000000000003423","article-title":"Multimodal assessments of drusenoid pigment epithelial detachments in the age-related eye disease study 2 ancillary spectral-domain optical coherence tomography study cohort","volume":"42","author":"Thavikulwat AT","year":"2022","unstructured":"Thavikulwat AT et al (2022) Multimodal assessments of drusenoid pigment epithelial detachments in the age-related eye disease study 2 ancillary spectral-domain optical coherence tomography study cohort. Retina 42(5):842\u2013851","journal-title":"Retina"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/bjo.2003.017632","article-title":"Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration","volume":"88","author":"Roquet W","year":"2004","unstructured":"Roquet W et al (2004) Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration. Br J Ophthalmol 88(5):638\u2013642","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report 8","volume":"119","author":"Group A","year":"2001","unstructured":"Group A (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report 8. Arch Ophthalmol 119(10):1417\u20131436","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/IIO.0000000000000543","article-title":"Photobiomodulation therapy for non-exudative age-related macular degeneration","volume":"65","author":"Rodriguez DA","year":"2025","unstructured":"Rodriguez DA et al (2025) Photobiomodulation therapy for non-exudative age-related macular degeneration. Int Ophthalmol Clin 65(1):47\u201352","journal-title":"Int Ophthalmol Clin"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40123-022-00640-6","article-title":"LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration","volume":"12","author":"Burton B","year":"2023","unstructured":"Burton B et al (2023) LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration. Ophthalmol Therapy 12(2):953\u2013968","journal-title":"Ophthalmol Therapy"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1007\/s40123-024-01030-w","article-title":"Safety, tolerability, and short-term efficacy of low-level light therapy for dry age-related macular degeneration","volume":"13","author":"Borrelli E","year":"2024","unstructured":"Borrelli E et al (2024) Safety, tolerability, and short-term efficacy of low-level light therapy for dry age-related macular degeneration. Ophthalmol Therapy 13(11):2855\u20132868","journal-title":"Ophthalmol Therapy"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/IAE.0000000000003980","article-title":"LIGHTSITE III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the Lumithera Valeda Light Delivery System","volume":"44","author":"Boyer D","year":"2024","unstructured":"Boyer D et al (2024) LIGHTSITE III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the Lumithera Valeda Light Delivery System. Retina 44(3):487\u2013497","journal-title":"Retina"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2024-002112","article-title":"Multimodal imaging biomarkers for progression from intermediate to advanced age-related macular degeneration (AMD): a 10-year prospective longitudinal cohort study from the University of Colorado AMD registry","volume":"10","author":"Gnanaraj R","year":"2025","unstructured":"Gnanaraj R et al (2025) Multimodal imaging biomarkers for progression from intermediate to advanced age-related macular degeneration (AMD): a 10-year prospective longitudinal cohort study from the University of Colorado AMD registry. BMJ Open Ophthalmol, 10(1)","journal-title":"BMJ Open Ophthalmol"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ophtha.2012.10.018","article-title":"Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci","volume":"120","author":"Christenbury JG","year":"2013","unstructured":"Christenbury JG et al (2013) Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology 120(5):1038\u20131045","journal-title":"Ophthalmology"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.oret.2022.09.007","article-title":"OCT risk factors for development of atrophy in eyes with intermediate age-related macular degeneration","volume":"7","author":"Hirabayashi K","year":"2023","unstructured":"Hirabayashi K et al (2023) OCT risk factors for development of atrophy in eyes with intermediate age-related macular degeneration. Ophthalmol Retina 7(3):253\u2013260","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"100100","DOI":"10.1016\/j.ajoint.2025.100100","article-title":"Natural history of non-neovascular pigment epithelial detachments (PEDs): Comparison between serous and drusenoid PEDs","volume":"2","author":"Goudot MM","year":"2025","unstructured":"Goudot MM et al (2025) Natural history of non-neovascular pigment epithelial detachments (PEDs): Comparison between serous and drusenoid PEDs. AJO Int 2(1):100100","journal-title":"AJO Int"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1120672119857896","article-title":"Systemic activation of the complement system in patients with advanced age-related macular degeneration","volume":"30","author":"Lynch AM","year":"2020","unstructured":"Lynch AM et al (2020) Systemic activation of the complement system in patients with advanced age-related macular degeneration. Eur J Ophthalmol 30(5):1061\u20131068","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/IAE.0000000000002023","article-title":"Colorado age-related macular degeneration registry: design and clinical risk factors of the cohort","volume":"39","author":"Lynch AM","year":"2019","unstructured":"Lynch AM et al (2019) Colorado age-related macular degeneration registry: design and clinical risk factors of the cohort. Retina 39(4):656\u2013663","journal-title":"Retina"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/tvst.11.5.22","article-title":"Sex and age-related differences in complement factors among patients with intermediate age-related macular degeneration","volume":"11","author":"Marin AI","year":"2022","unstructured":"Marin AI et al (2022) Sex and age-related differences in complement factors among patients with intermediate age-related macular degeneration. Translational Vis Sci Technol 11(5):22\u201322","journal-title":"Translational Vis Sci Technol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajo.2024.03.023","article-title":"Association between quantitative and qualitative imaging biomarkers and geographic atrophy growth rate","volume":"264","author":"Forest C","year":"2024","unstructured":"de Forest C (2024) Association between quantitative and qualitative imaging biomarkers and geographic atrophy growth rate. Am J Ophthalmol 264:168\u2013177","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris III","year":"2013","unstructured":"Ferris III (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120(4):844\u2013851","journal-title":"Ophthalmology"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ophtha.2009.12.002","article-title":"Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report 28","volume":"117","author":"Cukras C","year":"2010","unstructured":"Cukras C et al (2010) Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report 28. Ophthalmology 117(3):489\u2013499","journal-title":"Ophthalmology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2022.09.018","article-title":"Optical coherence tomography biomarkers for conversion to exudative neovascular age-related macular degeneration","volume":"247","author":"Wakatsuki Y","year":"2023","unstructured":"Wakatsuki Y et al (2023) Optical coherence tomography biomarkers for conversion to exudative neovascular age-related macular degeneration. Am J Ophthalmol 247:137\u2013144","journal-title":"Am J Ophthalmol"},{"key":"ref29","first-page":"3431","volume-title":"Quantity of intraretinal hyperreflective foci in patients with intermediate age-related macular degeneration correlates with 1-year progression","author":"Nassisi M","year":"2018","unstructured":"Nassisi M et al (2018) Quantity of intraretinal hyperreflective foci in patients with intermediate age-related macular degeneration correlates with 1-year progression, vol 59. Investigative ophthalmology & visual science, pp 3431\u20133439. 8"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","article-title":"A simplified severity scale for age-related macular degeneration: AREDS report 18","volume":"123","author":"Group A","year":"2005","unstructured":"Group A (2005) A simplified severity scale for age-related macular degeneration: AREDS report 18. Arch Ophthalmol 123(11):1570\u20131574","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"ref31","first-page":"3437","article-title":"Relationship between the distribution of intra-retinal hyper-reflective foci and the progression of intermediate age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology","volume":"261","author":"Verma A","year":"2023","unstructured":"Verma A et al (2023) Relationship between the distribution of intra-retinal hyper-reflective foci and the progression of intermediate age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology. 261(12):3437\u20133447"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.oret.2024.04.009","article-title":"Acquired vitelliform lesions in intermediate age-related macular degeneration: a cross sectional study","volume":"8","author":"Lindenberg S","year":"2024","unstructured":"Lindenberg S et al (2024) Acquired vitelliform lesions in intermediate age-related macular degeneration: a cross sectional study. Ophthalmol Retina 8(9):854\u2013862","journal-title":"Ophthalmol Retina"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.oret.2024.04.003","article-title":"Predictive factors influencing the evolution of Acquired Vitelliform lesions in Intermediate Age-related Macular Degeneration eyes","volume":"8","author":"Mahmoudi A","year":"2024","unstructured":"Mahmoudi A et al (2024) Predictive factors influencing the evolution of Acquired Vitelliform lesions in Intermediate Age-related Macular Degeneration eyes. Ophthalmol Retina 8(9):863\u2013871","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcjo.2021.01.005","article-title":"Natural history of incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration","volume":"56","author":"Corradetti G","year":"2021","unstructured":"Corradetti G et al (2021) Natural history of incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration. Can J Ophthalmol 56(5):325\u2013334","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ophtha.2019.09.035","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: classification of atrophy meeting report 4","volume":"127","author":"Guymer RH","year":"2020","unstructured":"Guymer RH et al (2020) Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: classification of atrophy meeting report 4. Ophthalmology 127(3):394\u2013409","journal-title":"Ophthalmology"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2022.09.004","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy: longitudinal evaluation in age-related macular degeneration","volume":"130","author":"Wu Z","year":"2023","unstructured":"Wu Z et al (2023) Incomplete retinal pigment epithelial and outer retinal atrophy: longitudinal evaluation in age-related macular degeneration. Ophthalmology 130(2):205\u2013212","journal-title":"Ophthalmology"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9193520\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9193520\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:57:25Z","timestamp":1784008645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9193520\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":36,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9193520\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,4,13]]},"subtype":"preprint"}}